Is Eovist Suitable for Arterial-Phase MR Imaging of Liver
Completed · Not applicable
Conditions studied: Liver Disease
In brief
To examine the quality of liver images produced when the contrast agent Eovist is used during MRI.
Key facts
- Study ID
- NCT02684526
- Run by
- University of Michigan
- People needed
- 198
- Starts
- 2011-12-01
- Expected to finish
- 2016-10-01
- Last updated by the study team
- 2016-12-16
Who can join
Age: 21 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- You have had a scheduled MRI(magnetic resonance imaging) scan using the contrast agent EOVIST.
- Male and females 21 years of age or older.
You may not qualify if…
- Does not have a contraindication for MRI (e.g. cardiac pacemaker, ferromagnetic or metallic implants).
- Pregnancy
Where it is running
- University of Michigan Hospital — Ann Arbor, Michigan, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.